Immunotherapy: PD-1-PD-L1 axis: efficient checkpoint blockade against cancer

Nat Rev Clin Oncol. 2015 Feb;12(2):63. doi: 10.1038/nrclinonc.2014.221. Epub 2014 Dec 23.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Female
  • Humans
  • Immunotherapy*
  • Male
  • Urinary Bladder Neoplasms / therapy*

Substances

  • Antibodies, Monoclonal